Allergy Relief Tablet
Product Images NDC 73581-201

3 FDA label images from Yyba Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Allergy Relief (NDC 73581-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Yyba Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

01b Lbl_allergy Relief_180mg_pdp (01b Lbl Allergy Relief 180mg Pdp)

01b Lbl_allergy Relief_180mg_pdp (01b Lbl Allergy Relief 180mg Pdp)
The packaging label for ALLERGY RELIEF tablets features Levocetirizine Dihydrochloride 5 mg strength. It indicates the product is an oral antihistamine providing 24-hour relief. The label highlights relief from runny nose, sneezing, itchy watery eyes, and itching of the nose or throat. The carton contains 180 tablets and is labeled by YYBA CORP with NDC 73581-201-60.*
FDA Label Image

01b Lbl_allergy Relief_180mg_df1 (01b Lbl Allergy Relief 180mg Df1)

01b Lbl_allergy Relief_180mg_df1 (01b Lbl Allergy Relief 180mg Df1)
Drug Facts panel for ALLERGY RELIEF Levocetirizine Dihydrochloride 5 mg oral tablets. The panel includes active ingredient and purpose (antihistamine), lists symptom relief uses for respiratory allergies, provides warnings regarding kidney disease and allergic reactions, advises consulting a doctor before use under certain conditions, and cautions about drowsiness and alcohol use.*
FDA Label Image

01b Lbl_allergy Relief_180mg_df2 (01b Lbl Allergy Relief 180mg Df2)

01b Lbl_allergy Relief_180mg_df2 (01b Lbl Allergy Relief 180mg Df2)
This Drug Facts panel for ALLERGY RELIEF (Levocetirizine Dihydrochloride) 5 mg tablets provides directions for use based on age groups, warnings about pregnancy, breastfeeding, and overdose, storage instructions, inactive ingredients, and contact information. It includes dosage instructions for adults, children aged 6-11, and those under 6 years, as well as warnings for consumers with kidney disease.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.